Product Information
CARBIDOPA-LEVO ER 50-200 TAB is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.1756 per EA under NDC 60219203401. Its NADAC has been published 147 times since Sep 6, 2023.
Strength
50; 200 mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
60219203401
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA076521On Market Since
12/21/2022
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVO ER 50-200 TAB has been published 147 times since Sep 6, 2023, and over the history we have for it it has declined 31.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1756 per EA |
|---|---|
| All-time high | $0.2606 (Nov 15, 2023) |
| All-time low | $0.1551 (May 22, 2024) |
| 52-week high | $0.2186 |
| 52-week low | $0.1756 |
| Median price | $0.2057 |
| Average price | $0.2058 |
| Largest weekly change | +52.4% (Jun 19, 2024) |
| Weeks tracked | 147 |
| Tracking since | Sep 6, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the CARBIDOPA and LEVODOPA market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVO ER 50-200 TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVO ER 50-200 TAB, manufactured by Amneal Pharmaceuticals NY LLC, is $0.1756 per EA (NDC 60219203401), effective Jun 24, 2026.
How has the price of CARBIDOPA-LEVO ER 50-200 TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVO ER 50-200 TAB has declined 31.1%. It has been tracked across 147 weekly CMS publications since Sep 6, 2023.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVO ER 50-200 TAB?
Since Sep 6, 2023, the NADAC for CARBIDOPA-LEVO ER 50-200 TAB has ranged from a low of $0.1551 (May 22, 2024) to a high of $0.2606 (Nov 15, 2023), with a median of $0.2057 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVO ER 50-200 TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CARBIDOPA-LEVO ER 50-200 TAB, so no direct lower-cost alternative is listed.
Who manufactures CARBIDOPA-LEVO ER 50-200 TAB?
CARBIDOPA-LEVO ER 50-200 TAB (NDC 60219203401) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification